Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer Cell Dysfunction and Its Role in COVID-19
Charmaine van Eeden, Lamia Khan, Mohammed Osman, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6351-6351
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease
Ludmila Müller, Svetlana Di Benedetto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 753-753
Open Access | Times Cited: 15
Institutionalising Multispecies Justice
Danielle Celermajer, Anthony Burke, Stefanie Fishel, et al.
(2025)
Closed Access | Times Cited: 2
Haemophagocytic syndrome and COVID-19
Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 4, pp. 1233-1244
Open Access | Times Cited: 82
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, et al.
Future Virology (2023) Vol. 18, Iss. 3, pp. 177-191
Open Access | Times Cited: 26
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
Joann Diray‐Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101079-101079
Open Access | Times Cited: 26
COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes
Е. С. Васичкина, D. Yu. Alekseeva, Igor Kudryavtsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1147-1147
Open Access | Times Cited: 23
From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity
Ludmila Müller, Svetlana Di Benedetto
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Terese Hammond, Marco A. Purbhoo, Sapana Kadel, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Off balance: Interferons in COVID-19 lung infections
Milena Apetito Akamatsu, Júlia Tavares de Castro, Carolina Yumi Takano, et al.
EBioMedicine (2021) Vol. 73, pp. 103642-103642
Open Access | Times Cited: 51
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107763-107763
Open Access | Times Cited: 49
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia‐Kubik
Cells (2021) Vol. 10, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 49
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
Rasoul Mirzaei, Adeleh Attar, Saher Papizadeh, et al.
Archives of Virology (2021) Vol. 166, Iss. 7, pp. 1819-1840
Open Access | Times Cited: 46
MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals
Erick C. Castelli, Mateus Vidigal de Castro, Michel Satya Naslavsky, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107586-107586
Open Access | Times Cited: 42
How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
Ludmila Müller, Svetlana Di Benedetto
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12539-12539
Open Access | Times Cited: 41
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Jiajing Zheng, Jiameng Miao, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 36
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 34
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
Igor Kudryavtsev, Artem Rubinstein, А. С. Головкин, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1082-1082
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top